APYX MEDICAL CORPORATION (APYX) Operating cash flow 2016–2025
APYX MEDICAL CORPORATION (APYX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.0MFY2025 · since FY2016: -$2.8M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | +55.7% |
| FY2024 | -$18.0M | -243.8% |
| FY2023 | -$5.2M | +74.1% |
| FY2022 | -$20.3M | -94.1% |
| FY2021 | -$10.4M | +35.0% |
| FY2020 | -$16.1M | +13.0% |
| FY2019 | -$18.5M | +11.5% |
| FY2018 | -$20.9M | -463.7% |
| FY2017 | -$3.7M | -30.6% |
| FY2016 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice